How many years of comparable data are there for Bhutan and Congo, Democratic Republic of the?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Bhutan vs Congo, Democratic Republic of the: Access to anti-retroviral drugs, female

Bhutan

80.0%

in 2024

Congo, Democratic Republic of the

78.0%

in 2024

Bhutan rank

57th

Congo, Democratic Republic of the rank

60th

Access to anti-retroviral drugs, female over time

Bhutan
Congo, Democratic Republic of the

How they compare

Bhutan currently reports 80.0% against 78.0% in Congo, Democratic Republic of the, a difference of 2.0%.

The two have swapped places 3 times across 25 shared years of data; in 2000 it was Congo, Democratic Republic of the ahead.

Bhutan ranks 57th and Congo, Democratic Republic of the ranks 60th of 141 countries.

Bhutan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Bhutan	Congo, Democratic Republic of the	Difference	Ahead
2000s	4.0%	2.0%	2.0%	Bhutan
2010s	46.2%	25.7%	20.5%	Bhutan
2020s	74.8%	70.2%	4.6%	Bhutan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Bhutan or Congo, Democratic Republic of the?: Bhutan, at 80.0% against 78.0% in Congo, Democratic Republic of the as of 2024.
What is the difference in access to anti-retroviral drugs, female between Bhutan and Congo, Democratic Republic of the?: 2.0%, with Bhutan ahead.
How many years of comparable data are there for Bhutan and Congo, Democratic Republic of the?: 25 years are reported by both, from 2000 to 2024.
How do Bhutan and Congo, Democratic Republic of the rank globally for access to anti-retroviral drugs, female?: Bhutan ranks 57th and Congo, Democratic Republic of the ranks 60th of 141 countries.
Where does this data come from?: UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bhutan vs Congo, Democratic Republic of the: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 14 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/bhutan/congo-dem-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/bhutan/congo-dem-rep/">Bhutan vs Congo, Democratic Republic of the: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator: Access to anti-retroviral drugs, female (%)
Unit: %
Source: UNAIDS estimates
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 160 places, 3,925 data points, 2000–2024
Last refreshed: 04 September 2026

The percentage of adult females living with HIV who are receiving antiretroviral therapy.